Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphomaAdrien Daniel, Louis Terriou, Mélanie Roriz et al.|European Journal Of Haematology|2022Cited by 8
Next-generation sequencing of TP53 mutations negates the need for FISH assessment in the investigation of TP53 aberrationsMark Catherwood, Anna Schuh, Doriane Cavalieri et al.|Leukemia & lymphoma/Leukemia and lymphoma|2020Cited by 0
TNFRSF17 genomic profiling guides retreatment with alternative BCMA-directed immunotherapies in multiple myelomaBenjamin Podvin, Salomon Manier, Holly Lee et al.|Blood Advances|2026Cited by 0